Evidence map›Paper›PMID 41857663›Full record

ArticleJournal of pharmaceutical health care and sciences2026

Comprehension of medication-related information translated from Japanese to Southeast Asian Languages using google translate.

Yumina Ako, Takafumi Sugawara, Sho Ishida, Kazuyuki Tanaka, Atsushi Watanabe

Abstract read
In one paragraph

Article in Journal of pharmaceutical health care and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yumina AkoDepartment of Pharmacy, Hiroshima City Hiroshima Citizens Hospital, 7-33 Motomachi, Naka-ku, Hiroshima, Hiroshima, 730-8518, Japan. ako-y@city-hosp.naka.hiroshima.jp.
Takafumi SugawaraDepartment of Pharmacy, Hiroshima City Hiroshima Citizens Hospital, 7-33 Motomachi, Naka-ku, Hiroshima, Hiroshima, 730-8518, Japan.
Sho IshidaPharmacy Division, Hiroshima City Rehabilitation Hospital, Hiroshima, Hiroshima, Japan.
Kazuyuki TanakaDepartment of Pharmacy, Hiroshima City Hiroshima Citizens Hospital, 7-33 Motomachi, Naka-ku, Hiroshima, Hiroshima, 730-8518, Japan.
Atsushi WatanabeDepartment of Pharmacy, Hiroshima City Hiroshima Citizens Hospital, 7-33 Motomachi, Naka-ku, Hiroshima, Hiroshima, 730-8518, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA workforce of foreign workers, mainly from Southeast Asia (SEA), is increasing because of an aging society and a declining birthrate. However, there are a few hospitals that can accept them. In this study, we evaluated whether SEA persons can understand medication-related information translated from Japanese into SEA languages using Google Translate.

methodsThe study was a questionnaire survey of simulated cases. Information on simulated cases in Japanese was translated into each target language using Google Translate. We set the answer to the questionnaire based on the simulated cases. Participants' backgrounds and answers to the questionnaire were aggregated for each target language and category.

resultsThe participants were 24 people from Thailand, Vietnam, Indonesia, and Burma. Comprehension outcomes differed across medications and information types. While understanding of main effects and side effects was generally adequate, comprehension of medication usage was limited, particularly for loxoprofen, with substantial variation across language groups.

conclusionsIt's challenging to communicate medical information accurately to the SEA patients when relying solely on Google Translate. Therefore, we may need to provide medication guidance orally to improve and enhance medication-related information, even if we cannot speak SEA languages.

Indexed as

Google TranslateLanguage barriersNon-Japanese patientsSoutheast AsiaThe translation application

Identifiers

PMID41857663
PMCPMC13003729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.